Status:
COMPLETED
Use of MRI and PET for Assessing Disease Activity in Takayasu's Arteritis
Lead Sponsor:
Peter Merkel
Collaborating Sponsors:
Office of Rare Diseases (ORD)
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Conditions:
Takayasu Arteritis
Eligibility:
All Genders
18+ years
Brief Summary
Assessing disease activity in people with Takayasu's arteritis is difficult, as most people with the disease do not exhibit visible, measurable symptoms. Combination positron emission tomography/compu...
Detailed Description
Takayasu's arteritis is a rare inflammatory disease that affects the aorta and its branches. The disease is much more common in females than in males, and disease onset typically occurs between the ag...
Eligibility Criteria
Inclusion
- Diagnosis of Takayasu's arteritis, as defined by the VCRC Longitudinal Study #5503
- Currently enrolled in the VCRC Longitudinal Study #5503
- Active disease has occurred in conjunction with a disease relapse within 2 weeks before study entry (A detailed definition of "active disease" is available in the study protocol.)
- Willing and able to comply with the schedule for imaging studies and follow-up procedures
Exclusion
- Pregnant or breastfeeding
- Unable to comply with study guidelines
- Unable to safely undergo MRI scanning
Key Trial Info
Start Date :
August 1 2008
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
September 30 2018
Estimated Enrollment :
26 Patients enrolled
Trial Details
Trial ID
NCT00744952
Start Date
August 1 2008
End Date
September 30 2018
Last Update
October 19 2018
Active Locations (5)
Enter a location and click search to find clinical trials sorted by distance.
1
Boston University School of Medicine
Boston, Massachusetts, United States, 02118
2
Mayo Clinic
Rochester, Minnesota, United States, 55905
3
Cleveland Clinic Foundation
Cleveland, Ohio, United States, 44195
4
St. Joseph's Healthcare
Hamilton, Ontario, Canada